What is the address of OSTEOPHYTO?

The registered office of OSTEOPHYTO is located at Dageraadstraat 5, 2980 Zoersel.

Is OSTEOPHYTO still active?

Yes. According to the CBE (1 October 2026) OSTEOPHYTO is active, legal situation “Normale toestand”, started on 14 October 2004.

Is OSTEOPHYTO registered on Peppol?

No, OSTEOPHYTO is currently not registered on the Peppol network.

What is the enterprise number of OSTEOPHYTO?

The enterprise number of OSTEOPHYTO is BE0867800701.

When was OSTEOPHYTO founded?

OSTEOPHYTO was founded on 14 October 2004.

Who are the directors of OSTEOPHYTO?

According to the 2024 annual accounts, the directors of OSTEOPHYTO are: Sigrid Van den Broeck.

Is OSTEOPHYTO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 October 2004; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did OSTEOPHYTO make in 2024?

OSTEOPHYTO recorded a loss after taxes of € 8,368 in financial year 2024.

What is the revenue of OSTEOPHYTO?

As a small company, OSTEOPHYTO is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 11,851.

OSTEOPHYTO (Private Limited) - Zoersel - BE0867800701

Dossier OSTEOPHYTO, printed on 1 October 2026 from databakkes.be/en/0867800701/osteophyto. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2023 and 2024.
Tight liquidity NBB

Cash and receivables cover 1 % of short-term debt in 2024; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

OSTEOPHYTO from Zoersel, company number BE0867800701, closed financial year 2024 with a result of € -8,368 after tax. For that financial year OSTEOPHYTO recorded a gross margin of € 11,851 and equity of € -60,302. Compared with financial year 2023, the result moved from € -8,617 to € -8,368. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 26, 2025.

What it is worth Caution

€ -60,302

▼ € 8,368 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8,368

▲ 3 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 190

▼ 58% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -79,302.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2024

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 122,679

▼ 7% vs 2023

€ 9,389 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 488

▼ 64% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 154

▲ 4% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 15,429 Gross margin 2021: € 15,429 First fiscal year in the series	€ 11,400 Gross margin 2022: € 11,400 ▼ 26% vs 2021 (€ 15,429) Unfavourable step	€ 12,391 Gross margin 2023: € 12,391 ▲ 9% vs 2022 (€ 11,400) Favourable step	€ 11,851 Gross margin 2024: € 11,851 ▼ 4% vs 2023 (€ 12,391) Unfavourable step	▼ 4%
Profit after taxes	€ -7,440 Profit after taxes 2021: € -7,440 First fiscal year in the series	€ -9,746 Profit after taxes 2022: € -9,746 ▼ € 2,306 vs 2021 (€ -7,440) Unfavourable step	€ -8,617 Profit after taxes 2023: € -8,617 ▲ € 1,130 vs 2022 (€ -9,746) Favourable step	€ -8,368 Profit after taxes 2024: € -8,368 ▲ € 248 vs 2023 (€ -8,617) Favourable step	▲ € 248
Equity	€ -33,571 Equity 2021: € -33,571 First fiscal year in the series	€ -43,317 Equity 2022: € -43,317 ▼ € 9,746 vs 2021 (€ -33,571) Unfavourable step	€ -51,934 Equity 2023: € -51,934 ▼ € 8,617 vs 2022 (€ -43,317) Unfavourable step	€ -60,302 Equity 2024: € -60,302 ▼ € 8,368 vs 2023 (€ -51,934) Unfavourable step	▼ € 8,368
Total debts	€ 149,487 Total debts 2021: € 149,487 First fiscal year in the series	€ 142,973 Total debts 2022: € 142,973 ▼ 4% vs 2021 (€ 149,487) Favourable step	€ 133,388 Total debts 2023: € 133,388 ▼ 7% vs 2022 (€ 142,973) Favourable step	€ 126,438 Total debts 2024: € 126,438 ▼ 5% vs 2023 (€ 133,388) Favourable step	▼ 5%
Cash	€ 8,052 Cash 2021: € 8,052 First fiscal year in the series	€ 2,994 Cash 2022: € 2,994 ▼ 63% vs 2021 (€ 8,052) Unfavourable step	€ 450 Cash 2023: € 450 ▼ 85% vs 2022 (€ 2,994) Unfavourable step	€ 190 Cash 2024: € 190 ▼ 58% vs 2023 (€ 450) Unfavourable step	▼ 58%
Land & buildings	€ 136,643 Land & buildings 2021: € 136,643 First fiscal year in the series	€ 119,506 Land & buildings 2022: € 119,506 ▼ 13% vs 2021 (€ 136,643) Unchanged	€ 102,393 Land & buildings 2023: € 102,393 ▼ 14% vs 2022 (€ 119,506) Unchanged	€ 85,280 Land & buildings 2024: € 85,280 ▼ 17% vs 2023 (€ 102,393) Unchanged	▼ 17%
Retained profit	€ -52,571 Retained profit 2021: € -52,571 First fiscal year in the series	€ -62,317 Retained profit 2022: € -62,317 ▼ € 9,746 vs 2021 (€ -52,571) Unfavourable step	€ -70,934 Retained profit 2023: € -70,934 ▼ € 8,617 vs 2022 (€ -62,317) Unfavourable step	€ -79,302 Retained profit 2024: € -79,302 ▼ € 8,368 vs 2023 (€ -70,934) Unfavourable step	▼ € 8,368
Bank debt	€ 148,242 Bank debt 2021: € 148,242 First fiscal year in the series	€ 140,891 Bank debt 2022: € 140,891 ▼ 5% vs 2021 (€ 148,242) Favourable step	€ 131,881 Bank debt 2023: € 131,881 ▼ 6% vs 2022 (€ 140,891) Favourable step	€ 122,679 Bank debt 2024: € 122,679 ▼ 7% vs 2023 (€ 131,881) Favourable step	▼ 7%
Balance sheet total	€ 150,304 Balance sheet total 2021: € 150,304 First fiscal year in the series	€ 129,746 Balance sheet total 2022: € 129,746 ▼ 14% vs 2021 (€ 150,304) Unchanged	€ 107,245 Balance sheet total 2023: € 107,245 ▼ 17% vs 2022 (€ 129,746) Unchanged	€ 87,629 Balance sheet total 2024: € 87,629 ▼ 18% vs 2023 (€ 107,245) Unchanged	▼ 18%

Key figures of OSTEOPHYTO, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to OSTEOPHYTO?

What happened at OSTEOPHYTO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 26, 2025 New annual accounts for financial year 2024: loss of € 8,368. filed late Source: NBB ↗
Oct 14, 2004 Start of the company according to the CBE. KBO
Oct 11, 2004 New establishment in Zoersel. KBO

In short

From € 7,440 loss in 2021 to € 8,368 loss in 2024.

Paid € 690 in corporate taxes since 2021.

Original PDFs at the National Bank ↗

A new publication or filing at OSTEOPHYTO? We notify you, reason included.

Follow OSTEOPHYTO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sigrid Van den Broeck

OSTEOPHYTO

Behind OSTEOPHYTO is Sigrid Van den Broeck.

See the full network in the app

Directors

According to the 2024 annual accounts

Sigrid Van den Broeck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dageraadstraat 5

2980 Zoersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0867.800.701
VAT number: BE 0867.800.701
Registered office: Dageraadstraat 5, 2980 Zoersel
Names & denominations: OSTEOPHYTO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 October 2004
Peppol: Not registered
Contact: [email protected] 0473/915247

View on CBE Public ↗ Annual accounts (NBB) ↗